Zhou et al. (2012) [11] and Yu et al. (2013) [12] reported that low expression of Beclin-1 predicted adverse OS and RFS of GC patients, indicating that Beclin-1 was a marker of better prognosis in GC. Here, BECN1 is linked to gastric cancer.